MNPR

Conviction 91HealthcareScan · Mon, Aug 10, 2026

Three outside down

MNPR$116.01-2.68%

ResistanceSupportVol 14

Vol MA14 352.82K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Monopar TherapeuticsPHARMACEUTICAL PREPARATIONSwww.monopartx.com ↗

Price116.01

Change-2.68%

Gap+0.74%

Rel volume1.95×

Avg volume322.15K

Avg $ vol35.8M

SMA 20111.51

SMA 5091.13

SMA 20072.05

Price vs 50+27.30%

Price vs 200+61.02%

MA stackbullish

50/200 cross—

Supertrendup · 99.09

RSI (14)61

MACD hist-0.51

MACD cross—

Stoch %K / %D63 / 73

ADX (14)39

+DI / −DI22 / 13

RSI divergence—

MACD divergence—

ATR %+6.43%

ADR %7.03%

52w high120.21

52w low30.42

From 52w high-3.49%

Above 52w low+281.36%

New 52w highNo

SqueezeOff

Bollinger width18.54%

%B0.72

Donchian pos67.24%

Donchian high124.82

Donchian low97.93

AVWAP (52w high)119.28

vs AVWAP high-2.74%

AVWAP (52w low)74.01

vs AVWAP low+56.76%

OBV trendFlat

Chaikin MF (20)0.02

Today vs 20d1.95×

Avg vol (14d)352.82K

Avg vol (20d)322.15K

Avg $ vol (20d)35.8M

Market cap777.16M

RS 3m (vs SPY)+85.25%

RS 6m (vs SPY)+95.47%

RS line new highNo

Trend template6/8

Technical rank89.1

1 week+3.91%

1 month+8.83%

3 months+82.48%

6 months+100.88%

1 year+189.30%

YTD+75.75%

P/E-56.66

P/B5.74

P/S—

P/FCF—

EPS-0.7300

Div yield—

ROE-10.13%

ROA-9.94%

Debt/Eq—

Current56.04

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth11.99%

Price target115.56

Target upside-0.39%

Analyst ratingBuy

Institutional97.17%

Ent. value724.61M

Revenue0

Net income-3.89M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out6.7M

Employees22

ListedThu, Dec 19, 2019

Free float4.1M

Float %61.4%

Short interest1.36M

Days to cover5.9d

Short volume69.5%

Squeeze score99 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.46 vs −$1.06

Last surprise+56.6% beat

Setup gradeA+

Conviction91 / 100

Pattern quality—

Tech rank89.1 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree outside down

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MNPR

All disclosures →

No recent disclosed trades by Congress in MNPR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MNPR · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Sweeny Nicole Director · Stock Options · 2026-06-26	Grant	1.28K	—	2026-06-26	2026-06-30

SEC filings

EDGAR filings in MNPR · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.